Nathalie Burg

Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases

T. Hla, J. Salmon, Nathalie Burg, 2022, Nature Reviews Rheumatology.

Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases

T. Hla, J. Salmon, Nathalie Burg, 2022, Nature Reviews Rheumatology.

An engineered S1P chaperone attenuates hypertension and ischemic injury

S. Swendeman, T. Hla, V. Blaho, 2017, Science Signaling.

Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury

S. Swendeman, T. Hla, J. Salmon, 2018, Arthritis & rheumatology.

Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1

C. Iadecola, T. Hla, J. Anrather, 2017, Proceedings of the National Academy of Sciences.

In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor-beta1.

D. Rifkin, B. Coller, K. Yoshinaga, 2008, Blood.

In vitro and in vivo evidence for shear-induced activation of latent transforming growth factor- 1

D. Rifkin, B. Coller, K. Yoshinaga, 2008 .